| http://www.w3.org/ns/prov#value | - y Of RochesterC35 tumor antigen specific monoclonal for use in diagnosis, prevention and treatment of cell proliferative disordersUS775420924 Dec 200313 Jul 2010Trubion PharmaceuticalsMolecularly engineered binding domain-immunoglobulin fusion proteins, including single chain Fv-immunoglobulin fusion protein useful for treating malignant conditions and B-cell disorders, such as disease caused by a
|
